UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 Date of report: For the month of April 2023 Commission File Number: 001-39084 Innate Pharma S.A. (Translation of registrant's name into English) Innate Pharma S.A. 117 Avenue de Luminy—BP 30191 13009 Marseille, France + 33 (0) 4 30 30 30 (Address of principal executive office) Indicate by check mark whether the registran ...